From the recent lessons of the Malagasy foci towards a global understanding of the factors involved in plague reemergence, Vet. Res, vol.36, pp.437-453, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00902976
, Wkly Epidemiol Rec, vol.79, pp.301-306, 2002.
Select agents and toxins list ,
, Federal Select Agent Program, 2014.
Plague as a biological weapon -Medical and public health management, J. Am. Med. Assoc, vol.283, pp.2281-2290, 2000. ,
Lessons learned from a full-scale bioterrorism exercise, Emerg Infect Dis, vol.6, pp.652-653, 2000. ,
Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis, Emerg. Infect. Dis, vol.7, pp.43-48, 2001. ,
Multidrug resistance in Yersinia pestis mediated by a transferable plasmid, N Engl J Med, vol.337, pp.677-680, 1997. ,
Multiple antimicrobial resistance in plague: an emerging public health risk, PLoS ONE, vol.2, p.309, 2007. ,
Plague immunization. I. Past and present trends, J Infect Dis, vol.129, pp.13-18, 1974. ,
Intraspecific diversity of Yersinia pestis, Clin Microbiol Rev, vol.17, pp.434-464, 2004. ,
,
,
Genome sequence of Yersinia pestis, the causative agent of plague, Nature, pp.523-527, 2001. ,
Defining the genome content of live plague vaccines by use of whole-genome DNA microarray, Vaccine, vol.22, pp.3367-3374, 2004. ,
Russian vaccines against especially dangerous bacterial pathogens, Emerg Microbes Infect, vol.3, p.86, 2014. ,
,
Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague, Infect. Immun, vol.63, pp.563-568, 1995. ,
Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen, J. Infect. Dis, vol.194, pp.1249-1257, 2006. ,
Recombinant raccoon pox vaccine protects mice against lethal plague, Vaccine, vol.21, pp.1232-1238, 2003. ,
Protection Against Experimental Bubonic and Pneumonic Plague By a Recombinant Capsular F1-V Antigen Fusion Protein Vaccine, Vaccine, vol.16, pp.1131-1137, 1998. ,
Roles of V antigen in promoting virulence and immunity in Yersiniae, J. Immunol, vol.133, pp.2226-2230, 1984. ,
Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague, Infect. Immun, vol.63, pp.2854-2858, 1995. ,
Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen, Vaccine, vol.22, pp.947-957, 2004. ,
Yersinia pestis CO92 Delta yopH is a potent live, attenuated plague vaccine, Clin. Vaccine Immunol, vol.14, pp.1235-1238, 2007. ,
Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates, Infect. Immun, vol.72, pp.908-915, 2004. ,
Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response, Nature Immunol, 2006. ,
A new improved sub-unit vaccine for plague: The basis of protection, FEMS Immunol. Med. Microbiol, vol.12, pp.223-230, 1995. ,
Current challenges in the development of vaccines for pneumonic plague, Expert Rev. Vaccines, vol.7, pp.209-221, 2008. ,
Yersinia pestis IS1541 transposition provides for escape from plague immunity, Infect. Immun, vol.77, pp.1807-1816, 2009. ,
, The economics of Planning and Preparing for Bioterrorism
, Bioterrorism and Infectious agents. A new dilemma for the 21st century, pp.237-257, 2005.
An Unusual Strain of Pasteurella pestis Isolated from a Fatal Human Case of Plague, Bull Org Mond Santé Bull Wld Hlth Org, vol.23, pp.408-409, 1960. ,
Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis, Proc. Natl. Acad. Sci. U.S.A, vol.101, pp.13826-13831, 2004. ,
Genetic variations of live attenuated plague vaccine strains (Yersinia pestis EV76 lineage) during laboratory passages in different countries, Infect Genet Evol, vol.26, pp.172-179, 2014. ,
Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis, Proc. Natl. Acad. Sci. U.S.A, vol.96, pp.14043-14048, 1999. ,
UNFPA joint statement on the use of auto-disable syringes in immunization services, 2003. ,
Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain, Infect Immun, vol.76, pp.3808-3816, 2008. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02075711
,
An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague, PLoS NTD, vol.6, p.1528, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01104077
The Yersinia high-pathogenicity island: an iron-uptake island, Microbiol. Infect, vol.3, pp.561-569, 2001. ,
L'immunité dans l'infection pesteuse. Acquisitions apportées par 30 années de travaux sur la souche de "Pasteurella pestis EV" (Girard et Robic), Biol. Méd, vol.52, pp.631-731, 1963. ,
A rapid and simple method for inactivating chromosomal genes in Yersinia, FEMS Immunol. Med. Microbiol, vol.38, pp.113-116, 2003. ,
Regulation of the Yersinia type III secretion system: traffic control, Front Cell Infect Microbiol, vol.3, p.4, 2013. ,
Early apoptosis of macrophages modulated by injection of Yersinia pestis YopK promotes progression of primary pneumonic plague, PLoS Pathog, vol.9, p.1003324, 2013. ,
,
A Yersinia Effector Protein Promotes Virulence by Preventing Inflammasome Recognition of the Type III Secretion System, Cell Host Microbe, vol.7, pp.376-387, 2010. ,
Effects of Psa and F1 on the adhesive and invasive interactions of Yersinia pestis with human respiratory tract epithelial cells, Infect. Immun, vol.74, pp.5636-5644, 2006. ,
Yersinia pestis pH-6 AntigenGenetic, Biochemical, and Virulence Characterization of a Protein Involved in the Pathogenesis of Bubonic Plague, Infect. Immun, vol.58, pp.2569-2577, 1990. ,
RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague, Proc. Natl. Acad. Sci. U.S.A, issue.103, pp.13514-13519, 2006. ,
,
The subcutaneous inoculation of pH 6 antigen mutants of Yersinia pestis does not affect virulence and immune response in mice, J. Med. Microbiol, vol.58, pp.26-36, 2009. ,
Antiphagocytic effect of F1 capsular protein of Yersinia pestis, Abstracts of the General Meeting of the, vol.97, p.96, 1997. ,
,
Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis, Clin. Infect. Dis, vol.21, pp.178-181, 1995. ,
Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops), Arch. Pathol. Lab. Med, vol.120, pp.156-163, 1996. ,
Yersinia pestis caf1 variants and the limits of plague vaccine protection, Infect. Immun, vol.76, pp.2025-2036, 2008. ,
The Dependence of the Yersinia pestis Capsule on Pathogenesis Is Influenced by the Mouse Background, Infect. Immun, vol.79, pp.644-652, 2011. ,
Recombinant Capsular Antigen (Fraction-1) from Yersinia pestis Induces a Protective Antibody Response in BALB/c Mice, Am. J. Trop. Med. Hyg, vol.43, pp.389-396, 1990. ,
Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis, Infect. Immun, vol.71, pp.2234-2238, 2003. ,
A Tn7-based broad-range bacterial cloning and expression system, Nat Methods, vol.2, pp.443-448, 2005. ,
Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination, PLoS Negl Trop Dis, vol.9, p.4162, 2015. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02067827
Lymphokine control of in vivo immunoglobulin isotype selection, Annu Rev Immunol, vol.8, pp.303-333, 1990. ,
Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation, Clin Exp Immunol, pp.143-151, 1985. ,
Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant, Vaccine, vol.32, pp.5035-5040, 2014. ,
Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague, Microb. Pathogen, vol.37, pp.177-184, 2004. ,
T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague, Vaccine, vol.29, pp.6866-6873, 2011. ,
Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection, Infect. Immun, vol.74, pp.3381-3386, 2006. ,
Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion, Immunity, pp.549-562, 2012. ,
IL-17 contributes to cellmediated defense against pulmonary Yersinia pestis infection, J Immunol, vol.186, pp.1675-1684, 2011. ,
, Th17 and regulatory T cells in mediating and restraining inflammation, pp.845-858, 2010.
,
TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology, Nat Immunol, vol.8, pp.1390-1397, 2007. ,
Recombinant fraction 1 protein of Yersinia pestis activates murine peritoneal macrophages in vitro, Cell. Immunol, vol.229, pp.52-61, 2004. ,
Structure and assembly of Yersinia pestis F1 antigen, Genus Yersinia: from Genomics to Function, vol.603, pp.74-87, 2007. ,
, Structure, assembly and applications of the polymeric F1 antigen of Yersinia pestis
, , pp.363-407, 2004.
Plague wars. The Terrifying Reality of Biological Warfare, 2001. ,
Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis, Am. J. Trop. Med. Hyg, vol.56, pp.471-473, 1997. ,